Диссертация (1145861), страница 15
Текст из файла (страница 15)
103-9.75. Iwata N., Tsubuki M., Takaki Y., Watanabe K., Sekiguchi,M., Hosoki E.,Kawashima-Morishima M., Lee H.J., Hama E., Sekine-Aizawa Y., Saido T.C.Identification of the major Abeta1-42-degrading catabolic pathway in brainparenchyma: suppression leads to biochemical and pathological deposition // NatureMed. 2000.
Т. 6. С. 143–150.76. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T.,Sisodia S., Malinow R. APP processing and synaptic function // Neuron. 2003. Т. 37. №6. С. 925-37.77. Kan R., Wang B., Zhang C., Jin F., Yang Z., Ji S., Lu Z., Zheng C., WangL. Genetic association of BACE1 gene polymorphism C786G with late-onsetAlzheimer's disease in Chinese // J. Mol. Neurosci. 2005 . Т.
25. № 2. С. 127-31.78. Kanemitsu H., Tomiyama T., Mori H. Human neprilysin is capable ofdegrading amyloid beta peptide not only in the monomeric form but also thepathological oligomeric form // Neuroscie Let. 2003. Т. 350. С. 113–116.79. Kim H.S., Kim E.M., Lee J.P., Park C.H., Kim S., Seo J.H., Chang K. A.,Yu.E., Jeong S.J., Chong Y.H. and Suh Y.H. C-terminal fragments of amyloid precursorprotein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression //FASEB J. 2003. Т. 17. С. 1951-1953.80.
Ko S.Y., Lin S.C., Chang K.W., Wong Y.K., Liu C.J., Chi C.W. and LiuT.Y. Increased expression of amyloid precursor protein in oral squamous cell carcinoma// International Journal of Cancer. 2004 Т. 111. С. 727-732.81. Kroner Z. The relationship between Alzheimer's disease and diabetes:Type 3 diabetes? // Altern. Med ReТ. 2009. Т.
14. № 4. С. 373-9.82. Kukar T., Prescott S., Eriksen J.L., Holloway Т., Murphy M.P., Koo E.H.Golde T.E., Nicolle M.M. Chronic administration of R-flurbiprofen attenuates learningimpairments in transgenic amyloid precursor protein mice // BMC Neurosci. 2007. Т. 8.С. 54.9583. Kunert N., Marhold J., Stanke J., Stach D., Lyko F.A. Dnmt2-like proteinmediates DNA methylation in Drosophila // Development.
2003. Т. 130. С. 5083-5090.84. Lai M.T., Chen E., Crouthamel M.C., DiMuzio-Mower J., Xu M., HuangQ., Price E., Register R.B., Shi X.P., Donoviel D.B., Bernstein A., Hazuda D., GardellS.J, Li Y.M. Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gammasecretase activities // J. Biol Chem. 2003. Т. 278. № 25. С. 22475-81.85. Xiong L., Gaspar C., Rouleau G.A. Genetics of Alzheimer's Disease andResearch Frontiers in Dementia // Geriatrics and Aging. 2005. Т. 8. № 4. С.
31-35.86. Lannfelt L. Blennow K., Zetterberg H., Batsman S., Ames D., Harrison J.,Masters C.L., Targum S., Bush A.I., Murdoch R., Wilson J., Ritchie C.W. Safety,efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy forAlzheimer’s disease: a phase IIa, double-blind, randomised, placebo-controlled trial //Lancet Neurol. 2008. Т.
9. С. 779–786.87. Laras Y., Garino C., Dessolin J., Weck C., Moret Т., Rolland A., KrausJ.L. New N(4)-substituted piperazine naphthamide derivatives as BACE-1 inhibitors // JEnzyme Inhib Med Chem. 2009. Т. 24. С. 181–187.88. Lee C.Y., Landreth G.E. The role of microglia in amyloid clearance fromthe AD brain // J. Neural Transm. 2010. Т. 117.
№ 8. С. 949-60.89. Lee J.Y., Friedman J.E., Angel I., Kozak A., Koh J.Y. The lipophilic metalchelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursorprotein transgenic mice // Neurobiol. Aging. 2004. Т. 25. № 10. С. 1315-21.90. Lee H.G., Casadesus G., Zhu X., Joseph J.A., Perry G, Smith M.A.Perspectives on the amyloid-beta cascade hypothesis // Alzheimers Dis. 2004. Т. 6. №2. С. 137-45.91. Leung D., Abbenante G., Fairlie D. С.
Protease inhibitors:current statusand future prospects // J. Med. Chem. 2000. Т. 43. С. 305–341.92. Li Y., Liu T., Peng Y., Yuan C. and Guo A.J. Specific functions ofDrosophila amyloid precursor-like protein in the development of nervous system andnon- neural tissues // Neurobiology. 2004. Т. 61. С. 343-358.9693. Liu C.C., Kanekiyo T., Xu H., Bu G. Apolipoprotein E and Alzheimerdisease: risk, mechanisms and therapy // Nat. Rev Neurol. 2013. Т.
9. № 2. С. 106-18.94. Lonze B.E., Ginty D.D. Function and regulation of CREB familytranscription factors in the nervous system // Neuron. 2002. Т. 3. С. 605–623.95. Love S., Barber R., Wilcock G.K. Increased poly(ADP-ribosyl)ation ofnuclear proteins in Alzheimer’s disease // Brain. 1999. Т. 122.
С. 247–253.96. Luo L., Martin-Morri L.E. and White K. Identification, secretion, andneural expression of APPL-Drosophila protein similar to human amyloid protein precursor // The Journal of Neuroscience. 1990. Т. 10. С. 3849-3861.97. Marcade M., Bourdin J., Loiseau N., Peillon H., Rayer A., Drouin D.,Schweighoffer F., Désiré L. Etazolate, a neuroprotective drug linking GABA(A)receptor pharmacology to amyloid precursor protein processing // J Neurochem.
2008.Т. 106. С. 392-404.98. Masliah E., Terry R. The role of synaptic proteins in the pathogenesis ofdisorders of the central nervous system // Brain Pathol. 1993. Т. 3. С. 77–85.99. Mastroeni D., Mckee A., Grover A., Rogers J., Coleman P.D. Epigeneticdifferences in cortical neurons from a pair of monozygotic twins discordant forAlzheimer’s disease // PLoS One. 2009. Т.
4. С. e6617.100.Mayeux R., Stern Y. Epidemiology of Alzheimer disease // ColdSpring Harb Perspect Med. 2012. Т. 2. С. 8.101.Merdes G., Soba P., Loewer A., Bilic M.Т. // EMBO J. 2004. Т. 23.С. 4082–4095.102.Mucke L., Masliah E., Yu G.Q., Mallory M., Rockenstein E.M.,Tatsuno G., Hu K., Kholodenko D., Johnson-Wood K., McConlogue L. High-levelneuronal expression of abeta 1–42 in wild-type human amyloid protein precursortransgenic mice. Synaptotoxicity without plaque formation // J Neurosci. 2000. Т. 20. С.4050–4058.103.Mufson E.J., Counts S.E., Ginsberg S.D. Gene expression profiles ofcholinergic nucleus basalis neurons in Alzheimer's disease // Neurochem Res. 2002. Т.27. № 10. С.
1035-4897104.Mullane K., Williams M. Alzheimer’s therapeutics: continuedclinical failures question the validity of the amyloid hypothesis — but what liesbeyond? // Biochem. Pharmacol. 2013. Т. 85. С. 289–305.105.Müller T., Meyer H.E., Egensperger R., Marcus K. The amyloidprecursor protein intracellular domain (AICD) as modulator of gene expression,apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease // ProgNeurobiol. 2008.
Т. 85. № 4. С. 393-406.106.Muller T., Concannon C.G., Ward M.W., Walsh C.M., TirniceriuA.L., Tribl F., Kögel D., Prehn J.H., Egensperger R. Modulation of gene expression andcytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD) //Mol. Biol Cell.
2007. Т. 18. С. 201–210.107.Müller U.C., Zheng H. Physiological functions of APP familyproteins // Cold Spring Harb Perspect Med. 2012. Т. 2. С. a006288.108.Murakami N., Yamaki T., Iwamoto Y., Sakakibara T., Kobori N.,Fushiki S., Ueda S. Experimental brain injury induces expression of amyloid precursorprotein, which may be related to neuronal loss in the hippocampus // J Neurotrauma.1998.
Т. 15. № 11. С. 993-1003.109.Neve R. and McPhie D. Dysfunction of amyloid precursor proteinsignaling in neurons leads to DNA synthesis and apoptosis // Biochim Biophys Acta.2007. Т. 1772. № 4. С. 430-437.110.Nevzglyadova O.Т., Kuznetsova I.M., Mikhailova E.Т., ArtamonovaT.O., Artemov A.Т., Mittenberg A.G., Kostyleva E.I., Turoverov K.K., KhodorkovskiiM.A., Soidla T.R.
The effect of red pigment on the amyloidization of yeast proteins //Yeast. 2011. Т. 28. № 7. С. 505-26.111.Niculescu M.D., Zeisel S.H. Diet, methyl donors and DNAmethylation: interactions between dietary folate, methionine and choline // J. Nutr.2002. Т. 132. С.
2333-2335.112.Nizzari M., Thellung, S., Corsaro A., Villa Т., Pagano A., Porcile C.,Russo C. and Florio T. Neurodegeneration in Alzheimer disease: Role of amyloid98precursor protein and presenilin 1 intracellular signaling // Journal of Toxicology. 2012.Т. 2012. 13 p.113.Nussbaum R., Ellis C.
Alzheimer's disease and Parkinson's disease //N Engl J Med. 2003. Т. 348. № 14. С. 1356-64.114.Ogawa O., Zhu X., Lee H.G., Raina A., Obrenovich M.E., BowserR., Ghanbari H.A., Castellani R.J., Perry G., Smith M.A. Ectopic localization ofphosphorylated histone H3 in Alzheimer’s disease: a mitotic catastrophe? // ActaNeuropathol. 2003. Т. 105. С.
524–528.115.Patterson C., Feightner J.W., Garcia A., Hsiung G.Y., MacKnightC., Sadovnick A.D. Diagnosis and treatment of dementia: risk assessment and primaryprevention of Alzheimer disease // CMAJ. 2008. Т. 178. № 5. С. 548–56.116.Peers C., Pearson H.A., Boyle J.С.
Hypoxia and Alzheimer's disease// Curr Alzheimer Res. 2008. Т. 6. С. 525-32.117.Pierrot N., Tyteca D., D'auria L., Dewachter I., Gailly P., HendrickxA., Tasiaux B., Haylani L.E., Muls N., N'kuli F., Laquerrière A., Demoulin J.B.,Campion D., Brion J.P., Courtoy P.J., Kienlen-Campard P., Octave J.N. Amyloidprecursor protein controls cholesterol turnover needed for neuronal activity // EMBOMol Med. 2013. Т. 4. С. 608-25.118.Plant L.D., Webster N.J., Boyle J.P., Ramsden M., Freir D.B., PeersC., Pearson H.A. Amyloid beta peptide as a physiological modulator of neuronal ‘A’type K+ current // Neurobiol Aging In Press.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
